According to a new research report by Precedence Research, The Single-Use Bioprocessing Market size is forecast to exceed US$ 52.5 billion by 2030 from USD 19 billion in 2020 and is expected to grow at the highest CAGR of 16.1% from 2021-2030. The report offers an up-to-date analysis regarding the current market scenario, latest trends, key drivers, potential challenges, profitability graph and the overall market environment.
Crucial factors accountable for market growth are:
- Rapid growth of the biopharmaceutical industry
- Growing government investments in the development of vaccines and drugs
- Rapid technological developments by the key players
- Rising government expenditure on developing healthcare infrastructure
- Increasing activities of the contract development manufacturing organizations
- Growing popularity of disposables in the biopharmaceuticals
Download the Sample Pages of this Report for Better Understanding@ https://www.precedenceresearch.com/sample/1308
Report Highlights
- By product, the media bags and containers segment led the global single-use bioprocessing market with remarkable revenue share in 2020. This is due to the benefits associated with the media bags and containers such as low capital requirement, saving of cost in sterilization and cleaning, operating scale flexibility, quick batch changeover and quick deployment, and cleaning validation elimination.
- By application, the filtration segment led the global single-use bioprocessing market with remarkable revenue share in 2020. This is attributed to the increasing adoption of single-use bioprocessing system in filtration owing to its flexibility. It is applicable in a wide variety of biopharmaceutical applications depending on the type of solutions used and is very much effective in eliminating viruses and other such cultures.
- By End User, the biopharmaceutical manufacturer segment led the market in 2020 as rapid growth of biopharmaceuticals industry. Biopharmaceutical industry alone represents over 20% of the total pharmaceutical industry and is rapidly growing across the markets like North America and Europe.
Scope of the Single-Use Bioprocessing Market Report
| Report Coverage | Details |
| Market Size in 2020 | US$ 19 billion in 2020 |
| Growth Rate from 2021 to 2030 | CAGR of 16.1% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Product, End User, Application, Workflow, Region |
| Companies Mentioned | General Electric Company (GE Healthcare), PBS Biotech, Inc., Thermo Fisher Scientific, Inc., Infors AG, Sartorius AG, Merck KGaA, Entegris, Inc., Lonza, Pall Corporation, Corning Incorporated, Eppendorf AG, Rentschler Biopharma SE |
Regional Snapshots
North America is the leading single-use bioprocessing market owing to the increased spending on healthcare, technological development in bioprocessing, and growing importance of life science research. Growing adoption of disposable systems and increased energy efficiency coupled with the minimal risk of product cross-contamination are the beneficial factors associated with the use of single-use bioprocessing products. Further, the introduction of automation, big data technology, and artificial intelligence in the single-use system has been gaining rapid traction in North America. These latest technologies in the manufacturing units are expected to boost production and helps the manufacturers to achieve cost-efficiency and reduce wastages.The presence of a large number of big and small contract manufacturing organizations in the region are increasingly using the single-use bioprocessing technology due to its low cost and improved output. The increased economic activity of these contract manufacturers will significantly drive the growth of the single-use bioprocessing market in North America.
Asia Pacific is characterized by growing production of biosimilars, cell therapy, vaccines, and various other types of biopharmaceutical products. Moreover, China is the second largest biopharmaceutical market just after the US. China’s economic policies to attract FDIs for setting up manufacturing plants for biopharmaceutical products is exponentially fostering the demand for single-use bioprocessing technology. Moreover, nations like India, Japan, and South Korea have been a leading player in the Asia Pacific region. Biocon of India and Samsung Biologics of South Korea have earned FDA and European Medicines Agency approval respectively, for their new biosimilar products in 2017. Therefore, the single-use bioprocessing market has huge growth potential in the Asia Pacific region.
Some of the prominent players in the single-use bioprocessing market include:
- Thermo Fisher Scientific, Inc.
- Sartorius AG
- Merck KGaA
- Pall Corporation
- Corning Incorporated
- Eppendorf AG
- General Electric Company (GE Healthcare)
- Lonza
- Rentschler Biopharma SE
- JM BioConnect
- Meissner Filtration Products, Inc.
- Infors AG
- BoehringerIngelheim GmbH
- Entegris, Inc.
- PBS Biotech, Inc.
Segments Covered in the Report
By Product
- Filtration Assemblies
- Disposable Bioreactors
- Disposable Mixers
- Media Bags & Containers
- Others
By Application
- Filtration
- Purification
- Cell Culture
- Others
By End User
- Biopharmaceutical Manufacturers
- Clinical & Academic Research Institutes
- Others
By Workflow
- Upstream
- Fermentation
- Downstream
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Single-Use Bioprocessing Market, By Product
7.1. Single-Use Bioprocessing Market, by Product Type, 2021-2030
7.1.1. Filtration Assemblies
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. Disposable Bioreactors
7.1.2.1. Market Revenue and Forecast (2019-2030)
7.1.3. Disposable Mixers
7.1.3.1. Market Revenue and Forecast (2019-2030)
7.1.4. Media Bags & Containers
7.1.4.1. Market Revenue and Forecast (2019-2030)
7.1.5. Others
7.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 8. Global Single-Use Bioprocessing Market, By Application
8.1. Single-Use Bioprocessing Market, by Application, 2021-2030
8.1.1. Filtration
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Purification
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Cell Culture
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Single-Use Bioprocessing Market, By End User Type
9.1. Single-Use Bioprocessing Market, by End User Type, 2021-2030
9.1.1. Biopharmaceutical Manufacturers
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Clinical & Academic Research Institutes
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Single-Use Bioprocessing Market, By Workflow Type
10.1. Single-Use Bioprocessing Market, by Workflow Type, 2021-2030
10.1.1. Upstream
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Fermentation
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Downstream
10.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Single-Use Bioprocessing Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.1.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.5.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.1.5.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.6.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.1.6.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.2.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.5.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.2.5.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.6.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.2.6.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.7.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.2.7.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.8.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.8.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.2.8.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.3.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.5.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.3.5.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.6.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.3.6.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.7.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.3.7.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.8.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.8.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.3.8.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.4.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.5.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.4.5.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.6.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.4.6.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.7.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.4.7.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.8.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.8.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.4.8.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.5.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.5.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.5.5.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.6.3. Market Revenue and Forecast, by End User Type (2019-2030)
11.5.6.4. Market Revenue and Forecast, by Workflow Type (2019-2030)
Chapter 12. Company Profiles
12.1. Thermo Fisher Scientific, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Sartorius AG
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Merck KGaA
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Pall Corporation
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Corning Incorporated
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Eppendorf AG
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. General Electric Company (GE Healthcare)
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Lonza
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Rentschler Biopharma SE
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. JM BioConnect
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Meissner Filtration Products, Inc.
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1308
About Us
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace &defense, among different ventures present globally.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
0 Comments